ArticleClinical ophthalmology (Auckland, N.Z.)2025
Longitudinal Choriocapillaris and Retinal Vascular Flow Changes on OCTA with Progression to Advanced AMD.
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Choriocapillaris Flow and Retinal Vascular Fractal Dimension in Dry Age-Related Macular Degeneration.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate retinal and choriocapillaris (CC) vascular flow changes on optical coherence tomography angiography (OCTA) associated with progression of intermediate age-related macular degeneration (iAMD) to geographic atrophy (GA) or neovascular AMD (nAMD). Patients and Methods: This retrospective, longitudinal cohort study included 68 eyes from 50 patients with iAMD at baseline who underwent OCTA and clinical examination at baseline and at 24 months. Quantitative analysis of CC flow deficits (FDs) and superficial capillary plexus vessel density (VD) was performed at baseline and after 24 months by comparing eyes that progressed to GA or nAMD to eyes that remained stable. Results: Over 24 months, 7 eyes (10.3%) developed GA and 9 eyes (13.2%) developed nAMD, including 2 that progressed to both. Eyes that developed GA had significantly greater CC FD total area at baseline when compared with stable iAMD eyes (p=0.013) and developed significant decrease in parafoveal VD (p=0.026) and full macular VD (p=0.019) after GA onset. In contrast, eyes that developed nAMD showed no significant OCTA differences at baseline when compared to stable iAMD eyes but developed a new significant increase in CC FD total area (p=0.044) and FAZ perimeter (p=0.036) after nAMD onset (p=0.044). Conclusion: In iAMD eyes progressing to GA, CC ischemia was detectable before GA onset, with subsequent retinal VD loss after GA development. In iAMD eyes progressing to nAMD, CC ischemia developed concurrent with neovascularization. OCTA-derived CC and retinal flow metrics may serve as non-invasive biomarkers to stratify iAMD eyes at risk for progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.